Redwood City, CA, United States of America

Jeff Alexander

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Emergent Travel Health Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeff Alexander. Retrieved from https://idiyas.com/inventor/jeff-alexander-ss6ilx9e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeff Alexander: Innovator in Vaccine Development

Introduction

Jeff Alexander is a notable inventor based in Redwood City, CA. He has made significant contributions to the field of vaccine development, particularly in relation to Toxoplasma gondii. His work focuses on innovative solutions to combat infections and improve public health.

Latest Patents

Jeff Alexander holds a patent for Toxoplasma gondii vaccines and their use. The patent discloses polynucleotides encoding multi-epitope polypeptides and assemblies thereof, aimed at treating or limiting infection. This innovative approach showcases his commitment to advancing medical science.

Career Highlights

Throughout his career, Jeff has been associated with Emergent Travel Health Inc., where he has played a crucial role in research and development. His expertise in vaccine technology has positioned him as a key figure in the industry.

Collaborations

Jeff has collaborated with esteemed colleagues, including Rima McLeod and Kamal El Bissati. These partnerships have further enhanced his research and contributed to the success of his projects.

Conclusion

Jeff Alexander's work in vaccine development exemplifies the impact of innovation in addressing health challenges. His contributions continue to pave the way for advancements in medical treatments and public health initiatives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…